114 related articles for article (PubMed ID: 17472714)
1. Habitual cocaine use is associated with high defibrillation threshold during ICD implantation.
Chen J; Naseem RH; Obel O; Joglar JA
J Cardiovasc Electrophysiol; 2007 Jul; 18(7):722-5. PubMed ID: 17472714
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Swiatecka G
Kardiol Pol; 2005 Apr; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
[TBL] [Abstract][Full Text] [Related]
3. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?
Osswald BR; De Simone R; Most S; Tochtermann U; Tanzeem A; Karck M
Eur J Cardiothorac Surg; 2009 Mar; 35(3):489-92. PubMed ID: 19144533
[TBL] [Abstract][Full Text] [Related]
4. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
[TBL] [Abstract][Full Text] [Related]
5. Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads.
Kettering K; Mewis C; Dörnberger V; Vonthein R; Bosch RF; Seipel L; Kühlkamp V
Pacing Clin Electrophysiol; 2004 Oct; 27(10):1355-61. PubMed ID: 15511244
[TBL] [Abstract][Full Text] [Related]
6. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
[TBL] [Abstract][Full Text] [Related]
7. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
[TBL] [Abstract][Full Text] [Related]
8. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
[TBL] [Abstract][Full Text] [Related]
9. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
[TBL] [Abstract][Full Text] [Related]
10. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
11. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
[TBL] [Abstract][Full Text] [Related]
12. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
[TBL] [Abstract][Full Text] [Related]
13. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
[TBL] [Abstract][Full Text] [Related]
14. ICD Implantation in infants and small children: the extracardiac technique.
Kriebel T; Ruschewski W; Gonzalez y Gonzalez M; Walter K; Kroll J; Kampmann C; Heinemann M; Schneider H; Paul T
Pacing Clin Electrophysiol; 2006 Dec; 29(12):1319-25. PubMed ID: 17201837
[TBL] [Abstract][Full Text] [Related]
15. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
16. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations.
Stephenson EA; Cecchin F; Walsh EP; Berul CI
J Cardiovasc Electrophysiol; 2005 Jan; 16(1):69-73. PubMed ID: 15673391
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
[TBL] [Abstract][Full Text] [Related]
18. The quick-implantable-defibrillator trial.
Bänsch D; Kottkamp H; Grönefeld G; Vogt J; Israel C; Böcker D; Hindricks G; Kuck KH;
Europace; 2007 Dec; 9(12):1144-50. PubMed ID: 17913695
[TBL] [Abstract][Full Text] [Related]
19. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
[TBL] [Abstract][Full Text] [Related]
20. The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series.
Cooper JA; Latacha MP; Soto GE; Garmany RG; Gleva MJ; Chen J; Faddis MN; Smith TW
Pacing Clin Electrophysiol; 2008 Nov; 31(11):1405-10. PubMed ID: 18950297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
